Grifols, S.A. (GRFS) Social Stream



Grifols, S.A. (GRFS): $9.71

0.02 (+0.21%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

D

Add GRFS to Watchlist
Sign Up

GRIFOLS SA (GRFS) Price Targets From Analysts

Use the tables below to see what analysts covering GRIFOLS SA think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-05 3 $17.7 $17.7 $17.7 $9.66 83.23%
2021-11-14 4 $19.2 $17.7 $18.45 $9.66 90.99%
2022-01-04 3 $12.5 $12.5 $12.5 $9.66 29.4%
2022-03-04 4 $13 $13 $13 $9.66 34.58%
2022-09-14 3 $10.4 $10.4 $10.4 $9.66 7.66%
2022-12-05 2 $9.15 $9.15 $9.15 $9.66 -5.28%
2023-01-03 2 $9 $9 $9 $9.66 -6.83%
2023-07-17 2 $9 $9 $9 $9.66 -6.83%
2023-09-05 3 $10 $10 $10 $9.66 3.52%
2023-11-14 3 $15 $10 $12.5 $9.66 29.4%

The Trend in the Analyst Price Target


GRFS's average price target has moved down $17.38 over the prior 37 months.

Over the past 49 weeks, GRFS's average upside potential has been 19.14%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-05 2 9.15 9.15 9.15 8.47 8.03%
2023-01-03 2 9.00 9.00 9.00 8.74 2.97%
2023-03-16 2 9.00 9.00 9.00 6.87 31%
2023-09-05 3 10.00 10.00 10.00 9.31 7.41%
2023-09-12 3 15.00 10.00 12.50 9.70 28.87%

GRFS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


Over the past 35 weeks, GRFS's average broker recommendation rating improved by 0.33.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how GRIFOLS SA fares relative to all US stocks, note that its variance in analysts' estimates is lower than 47.18% of that group.
  • In terms of how GRIFOLS SA fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 14.4% of that group.
  • In terms of how GRIFOLS SA fares relative to stocks in the large market cap category, note that its average analyst price target is higher than 67.66% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, GRIFOLS SA's upside potential (average analyst target price relative to current price) is greater than 199.56% of them.

In the Pharmaceutical Products industry, SNY, GLPG, and VTRS are the three stocks most similar to GRIFOLS SA regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding GRFS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!